flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 in CKD - The (Journal Club Idol) FLOW: Kidney outcome results for

I love coming to this clinic

It joins the growing ranks of corporate donors to the fund, including Facebook $META parent company Meta (META), Amazon $AMZN (AMZN), OpenAI, Uber $UBER (UBER), and Bank of America $BAC (BAC)

Compounded tirzepatide is prepared by compounding pharmacies according to patients needs

Some researchers prefer morning injections, others prefer evening

Potluri, an Obesity Medicine specialist, to discuss how these advances shaped our current approach to patients with cardiometabolic disease and what the future might hold as progress continued in this exciting area of health care

Clinical studies show modest weight loss of 2-5 pounds over 12 weeks, with more significant improvements in metabolic markers like fasting glucose and HbA1c